Another drug development project in Captor’s portfolio has received funding!
Discovery and development of non-toxic ligase ligands and their application in the treatment of autoimmunological diseases will be supported with over 27 M PLN grant from the European Regional Development Fund through Smart Growth Operational Programme 2014-2020 (project number: POIR.01.01.01-00-0741/19).
Foto: Piotr Piatek
Share:
